全球医院获得性疾病检测市场研究报告-产业分析、规模、份额、成长、趋势和预测 2025 年至 2033 年

全球医院获得性疾病检测市场规模预计将从 2024 年的 154.8 亿美元增长到 2033 年的 663 亿美元，在 2026 年至 2033 年的预测期内呈现 17.54% 的强劲年复合成长率(CAGR)。

受医院内感染（HAI）发病率不断上升以及对患者安全和护理品质日益重视的推动，医院内疾病检测市场将经历强劲增长。随着医院和医疗机构努力降低医院感染风险，对准确、快速的诊断检测方法的需求变得至关重要。抗生素抗药性病原体的增加进一步使情况复杂化，需要先进的检测解决方案来快速识别感染的病原体并指导适当的治疗策略。人们越来越意识到医院感染对病患治疗结果和医疗成本的影响，进而推动了市场的发展。

诊断测试技术的进步正在彻底改变医院内感染疾病检测市场。分子诊断、即时诊断和下一代定序等创新正在提高病原体检测的速度和准确性。这些技术使医疗保健提供者能够及时采取干预措施，减少住院时间并改善患者的整体治疗效果。此外，包括电子健康记录和实验室资讯系统在内的数位健康解决方案的整合正在简化资料管理并促进医疗团队之间的更好沟通，从而进一步提高感染控制措施的效率。

此外，医院内感染检测市场将受益于监管审查力度的加强和旨在减少医院内感染的公共卫生措施。随着医疗保健机构采用严格的感染预防协议，对全面检测解决方案的需求将会上升。诊断公司、医疗保健提供者和监管机构之间的合作努力对于制定标准化测试指南和确保广泛采用最佳实践至关重要。随着市场的发展，重点将转向将检测整合到更广泛的感染控制策略中，强调监测、早期发现和有针对性的干预在对抗医院内感染疾病的重要性。

我们的报告经过精心製作，为客户提供有关各个行业和市场的全面且可操作的见解。每份报告都包含几个关键部分，以确保彻底了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本节探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准将市场细分为不同的细分市场。该分析强调了每个部分的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本节深入介绍领先公司的竞争动态和关键策略。

市场预测：根据历史资料和当前市场状况，预测特定时期内的市场规模和成长趋势。这包括定量分析和图形表示来说明未来的市场轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前和新兴的市场趋势、技术创新和潜在投资领域。本节提供未来市场发展和成长前景的见解。

目录

第 1 章：前言

• 报告描述
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法
  • 市场研究流程
  • 市场研究方法

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：医院获得性疾病检测产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业趋势
• 波特五力分析
• 市场吸引力分析
  • 按测试类型进行市场吸引力分析
  • 最终用户的市场吸引力分析
  • 市场吸引力分析：按地区

第四章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料製造商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球医院获得性疾病检测市场分析：按检测类型

• 按测试类型概览
• 按测试类型进行的历史和预测资料分析
• 泌尿道感染
• 手术部位感染
• 肺炎支架
• 血流感染
• 抗甲氧西林金黄色葡萄球菌
• 其他的

第 6 章：全球医院获得性疾病检测市场分析：按最终用户

• 最终用户概览
• 最终用户的历史和预测数据分析
• 医院及重症加护病房 (ICUS)
• 门诊手术及诊断中心
• 安养院及妇产中心
• 公司

第 7 章：全球医院获得性疾病检测市场分析：按地区划分

• 区域展望
• 介绍
• 北美销售分析
  • 概述、历史和预测数据销售分析
  • 北美各细分市场销售分析
  • 北美各国销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概述、历史和预测数据销售分析
  • 欧洲各细分市场销售分析
  • 欧洲各国销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概述、历史和预测数据销售分析
  • 亚太地区分部销售分析
  • 亚太地区国家销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概述、历史和预测数据销售分析
  • 拉丁美洲各细分市场销售分析
  • 拉丁美洲各国销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概述、历史和预测数据销售分析
  • 中东和非洲分部销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东和非洲其他地区销售分析

第 8 章：医院获得性疾病检测公司的竞争格局

• 医院获得性疾病检测市场竞争
• 伙伴关係/合作/协议
• 合併与收购
• 新产品发布
• 其他进展

第九章：公司简介

• 顶级公司市占率分析
• 市场集中度
• Abbott
• 公司概况
• 公司收入
• 产品
• 最新动态
• Eurofins Scientific
• 公司概况
• 公司收入
• 产品
• 最新动态
• BIOMÉRIEUX
• 公司概况
• 公司收入
• 产品
• 最新动态
• Cantel Medical
• 公司概况
• 公司收入
• 产品
• 最新动态
• Meridian Bioscience Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• QIAGEN
• 公司概况
• 公司收入
• 产品
• 最新动态
• F. Hoffmann-La Roche Ltd
• 公司概况
• 公司收入
• 产品
• 最新动态
• BD
• 公司概况
• 公司收入
• 产品
• 最新动态
• Hologic Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Siemens Healthcare Private Limited
• 公司概况
• 公司收入
• 产品
• 最新动态
• Thermo Fisher Scientific Inc.
• 公司概况
• 公司收入
• 产品
• 最新动态
• Medtronic
• 公司概况
• 公司收入
• 产品
• 最新动态
• Getinge AB
• 公司概况
• 公司收入
• 产品
• 最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，对于私人公司，可能不予涵盖

Global Hospital Acquired Disease Testing Market size is anticipated to grow from USD 15.48 Billion in 2024 to USD 66.3 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 17.54% during the forecast period of 2026 to 2033.

The hospital-acquired disease testing market is set to experience robust growth, driven by the increasing incidence of healthcare-associated infections (HAIs) and the growing emphasis on patient safety and quality of care. As hospitals and healthcare facilities strive to minimize the risk of HAIs, the demand for accurate and rapid diagnostic testing methods is becoming paramount. The rise in antibiotic-resistant pathogens further complicates the landscape, necessitating advanced testing solutions that can quickly identify the causative agents of infections and guide appropriate treatment strategies. This growing awareness of the impact of HAIs on patient outcomes and healthcare costs is propelling the market forward.

Technological advancements in diagnostic testing are revolutionizing the hospital-acquired disease testing market. Innovations such as molecular diagnostics, point-of-care testing, and next-generation sequencing are enhancing the speed and accuracy of pathogen detection. These technologies enable healthcare providers to implement timely interventions, reducing the duration of hospital stays and improving overall patient outcomes. Additionally, the integration of digital health solutions, including electronic health records and laboratory information systems, is streamlining data management and facilitating better communication among healthcare teams, further enhancing the efficiency of infection control measures.

Moreover, the hospital-acquired disease testing market will benefit from increased regulatory scrutiny and public health initiatives aimed at reducing HAIs. As healthcare organizations adopt stringent infection prevention protocols, the demand for comprehensive testing solutions will rise. Collaborative efforts between diagnostic companies, healthcare providers, and regulatory bodies will be essential in developing standardized testing guidelines and ensuring the widespread adoption of best practices. As the market evolves, the focus will shift towards integrating testing into broader infection control strategies, emphasizing the importance of surveillance, early detection, and targeted interventions in combating hospital-acquired diseases.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Test Type

• Urinary Tract Infection
• Surgical Site Infection
• Pneumonia Stents
• Blood Stream Infection
• Methicillin-Resistant Staphylococcus Aureus
• Others

By End User

• Hospitals and Intensive Care Units (ICUS)
• Ambulatory Surgical and Diagnostic Centers
• Nursing Homes and Maternity Centers
• Companies
• COMPANIES PROFILED
• Abbott
• Eurofins Scientific
• BIOMERIEUX
• Cantel Medical
• Meridian Bioscience Inc.
• QIAGEN
• F. Hoffmann-La Roche Ltd
• BD
• Hologic Inc.
• Siemens Healthcare Private Limited
• Thermo Fisher Scientific Inc.
• Medtronic
• Getinge AB
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. HOSPITAL ACQUIRED DISEASE TESTING INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Test Type
  • 3.7.2 Market Attractiveness Analysis By End User
  • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET ANALYSIS BY TEST TYPE

• 5.1. Overview By Test Type
• 5.2. Historical and Forecast Data Analysis By Test Type
• 5.3. Urinary Tract Infection Historic and Forecast Sales By Regions
• 5.4. Surgical Site Infection Historic and Forecast Sales By Regions
• 5.5. Pneumonia Stents Historic and Forecast Sales By Regions
• 5.6. Blood Stream Infection Historic and Forecast Sales By Regions
• 5.7. Methicillin-Resistant Staphylococcus Aureus Historic and Forecast Sales By Regions
• 5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET ANALYSIS BY END USER

• 6.1. Overview By End User
• 6.2. Historical and Forecast Data Analysis By End User
• 6.3. Hospitals and Intensive Care Units (ICUS) Historic and Forecast Sales By Regions
• 6.4. Ambulatory Surgical and Diagnostic Centers Historic and Forecast Sales By Regions
• 6.5. Nursing Homes and Maternity Centers Historic and Forecast Sales By Regions
• 6.6. Companies Historic and Forecast Sales By Regions

7. GLOBAL HOSPITAL ACQUIRED DISEASE TESTING MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2 North America By Segment Sales Analysis
  • 7.3.3 North America By Country Sales Analysis
  • 7.3.4 United States Sales Analysis
  • 7.3.5 Canada Sales Analysis
  • 7.3.6 Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2 Europe By Segment Sales Analysis
  • 7.4.3 Europe By Country Sales Analysis
  • 7.4.4 United Kingdom Sales Analysis
  • 7.4.5 France Sales Analysis
  • 7.4.6 Germany Sales Analysis
  • 7.4.7 Italy Sales Analysis
  • 7.4.8 Russia Sales Analysis
  • 7.4.9 Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2 Asia Pacific By Segment Sales Analysis
  • 7.5.3 Asia Pacific By Country Sales Analysis
  • 7.5.4 China Sales Analysis
  • 7.5.5 India Sales Analysis
  • 7.5.6 Japan Sales Analysis
  • 7.5.7 South Korea Sales Analysis
  • 7.5.8 Australia Sales Analysis
  • 7.5.9 South East Asia Sales Analysis
  • 7.5.10 Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2 Latin America By Segment Sales Analysis
  • 7.6.3 Latin America By Country Sales Analysis
  • 7.6.4 Brazil Sales Analysis
  • 7.6.5 Argentina Sales Analysis
  • 7.6.6 Peru Sales Analysis
  • 7.6.7 Chile Sales Analysis
  • 7.6.8 Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2 Middle East & Africa By Segment Sales Analysis
  • 7.7.3 Middle East & Africa By Country Sales Analysis
  • 7.7.4 Saudi Arabia Sales Analysis
  • 7.7.5 UAE Sales Analysis
  • 7.7.6 Israel Sales Analysis
  • 7.7.7 South Africa Sales Analysis
  • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE HOSPITAL ACQUIRED DISEASE TESTING COMPANIES

• 8.1. Hospital Acquired Disease Testing Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9. COMPANY PROFILES OF HOSPITAL ACQUIRED DISEASE TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Abbott
  • 9.3.1 Company Overview
  • 9.3.2 Company Revenue
  • 9.3.3 Products
  • 9.3.4 Recent Developments
• 9.4. Eurofins Scientific
  • 9.4.1 Company Overview
  • 9.4.2 Company Revenue
  • 9.4.3 Products
  • 9.4.4 Recent Developments
• 9.5. BIOMÉRIEUX
  • 9.5.1 Company Overview
  • 9.5.2 Company Revenue
  • 9.5.3 Products
  • 9.5.4 Recent Developments
• 9.6. Cantel Medical
  • 9.6.1 Company Overview
  • 9.6.2 Company Revenue
  • 9.6.3 Products
  • 9.6.4 Recent Developments
• 9.7. Meridian Bioscience Inc.
  • 9.7.1 Company Overview
  • 9.7.2 Company Revenue
  • 9.7.3 Products
  • 9.7.4 Recent Developments
• 9.8. QIAGEN
  • 9.8.1 Company Overview
  • 9.8.2 Company Revenue
  • 9.8.3 Products
  • 9.8.4 Recent Developments
• 9.9. F. Hoffmann-La Roche Ltd
  • 9.9.1 Company Overview
  • 9.9.2 Company Revenue
  • 9.9.3 Products
  • 9.9.4 Recent Developments
• 9.10. BD
  • 9.10.1 Company Overview
  • 9.10.2 Company Revenue
  • 9.10.3 Products
  • 9.10.4 Recent Developments
• 9.11. Hologic Inc.
  • 9.11.1 Company Overview
  • 9.11.2 Company Revenue
  • 9.11.3 Products
  • 9.11.4 Recent Developments
• 9.12. Siemens Healthcare Private Limited
  • 9.12.1 Company Overview
  • 9.12.2 Company Revenue
  • 9.12.3 Products
  • 9.12.4 Recent Developments
• 9.13. Thermo Fisher Scientific Inc.
  • 9.13.1 Company Overview
  • 9.13.2 Company Revenue
  • 9.13.3 Products
  • 9.13.4 Recent Developments
• 9.14. Medtronic
  • 9.14.1 Company Overview
  • 9.14.2 Company Revenue
  • 9.14.3 Products
  • 9.14.4 Recent Developments
• 9.15. Getinge AB
  • 9.15.1 Company Overview
  • 9.15.2 Company Revenue
  • 9.15.3 Products
  • 9.15.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Test Type (Units and USD MN)
• Urinary Tract Infection Market Sales By Geography (Units and USD MN)
• Surgical Site Infection Market Sales By Geography (Units and USD MN)
• Pneumonia Stents Market Sales By Geography (Units and USD MN)
• Blood Stream Infection Market Sales By Geography (Units and USD MN)
• Methicillin-Resistant Staphylococcus Aureus Market Sales By Geography (Units and USD MN)
• Others Market Sales By Geography (Units and USD MN)
• Analysis By End User (Units and USD MN)
• Hospitals and Intensive Care Units (ICUS) Market Sales By Geography (Units and USD MN)
• Ambulatory Surgical and Diagnostic Centers Market Sales By Geography (Units and USD MN)
• Nursing Homes and Maternity Centers Market Sales By Geography (Units and USD MN)
• Companies Market Sales By Geography (Units and USD MN)
• Global Hospital Acquired Disease Testing Market Sales By Geography (Units and USD MN)
• North America Market Analysis (Units and USD MN)
• United States Market Analysis (Units and USD MN)
• Canada Market Analysis (Units and USD MN)
• Mexico Market Analysis (Units and USD MN)
• Europe Market Analysis (Units and USD MN)
• Europe Market Estimate By Country (Units and USD MN)
• United Kingdom Market Analysis (Units and USD MN)
• France Market Analysis (Units and USD MN)
• Germany Market Analysis (Units and USD MN)
• Italy Market Analysis (Units and USD MN)
• Russia Market Analysis (Units and USD MN)
• Spain Market Analysis (Units and USD MN)
• Rest of Europe Market Analysis (Units and USD MN)
• Asia Pacific Market Analysis (Units and USD MN)
• China Market Analysis (Units and USD MN)
• Japan Market Analysis (Units and USD MN)
• India Market Analysis (Units and USD MN)
• South Korea Market Analysis (Units and USD MN)
• Australia Market Analysis (Units and USD MN)
• South East Asia Market Analysis (Units and USD MN)
• Rest of Asia Pacific Market Analysis (Units and USD MN)
• Latin America Market Analysis (Units and USD MN)
• Brazil Market Analysis (Units and USD MN)
• Argentina Market Analysis (Units and USD MN)
• Peru Market Analysis (Units and USD MN)
• Chile Market Analysis (Units and USD MN)
• Rest of Latin America Market Analysis (Units and USD MN)
• Middle East & Africa Market Analysis (Units and USD MN)
• Saudi Arabia Market Analysis (Units and USD MN)
• UAE Market Analysis (Units and USD MN)
• Israel Market Analysis (Units and USD MN)
• South Africa Market Analysis (Units and USD MN)
• Rest of Middle East and Africa Market Analysis (Units and USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Hospital Acquired Disease Testing Report
• Market Research Process
• Market Research Methodology
• Global Hospital Acquired Disease Testing Market Size, By Region (Units and USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Test Type
• Market Attractiveness Analysis By End User
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Test Type (Units and USD MN)
• Urinary Tract Infection Market Sales By Geography (Units and USD MN)
• Surgical Site Infection Market Sales By Geography (Units and USD MN)
• Pneumonia Stents Market Sales By Geography (Units and USD MN)
• Blood Stream Infection Market Sales By Geography (Units and USD MN)
• Methicillin-Resistant Staphylococcus Aureus Market Sales By Geography (Units and USD MN)
• Others Market Sales By Geography (Units and USD MN)
• Global Market Analysis By End User (Units and USD MN)
• Hospitals and Intensive Care Units (ICUS) Market Sales By Geography (Units and USD MN)
• Ambulatory Surgical and Diagnostic Centers Market Sales By Geography (Units and USD MN)
• Nursing Homes and Maternity Centers Market Sales By Geography (Units and USD MN)
• Companies Market Sales By Geography (Units and USD MN)
• Global Market Sales (Units and USD MN)
• North America Market Sales (Units and USD MN)
• Europe Market Sales (Units and USD MN)
• Asia Pacific Market Sales (Units and USD MN)
• Latin America Market Sales (Units and USD MN)
• Middle East & Africa Market Sales (Units and USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis
• Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.